• Most Popular
  • Most Shared

Intercell says JE vaccine phase II trial a success

Tue Apr 15, 2008 3:25am EDT

Stocks

   

VIENNA, April 15 (Reuters) - Austrian vaccine maker Intercell (ICEL.VI) said on Tuesday data from a phase II trial of its Japanese Encephalitis (JE) vaccine have shown excellent results amongst children in endemic regions.

"The results fully support Intercell's development plan for endemic regions and pave the way towards late stage development and licensure -- planned for late 2009 / early 2010," the company said in a statement.

Intercell wants the vaccine to be licensed for use in children in India and other parts of South East Asia with its Indian partner Biological E Ltd. Phase III clinical trials in India are planned for the end 2008/early 2009.

Novartis AG (NOVN.VX) has a marketing and distribution agreement for the new vaccine for the United States, Europe and other markets in Asia and Latin America with Intercell.

With over 3 billion people living in endemic areas, mosquito-borne Japanese encephalitis is the leading cause of childhood encephalitis and viral encephalitis in Asia. (Reporting by Sylvia Westall)



More from Reuters

Afghan suicide blast kills eight U.S. civilians

KABUL (Reuters) - A suicide bomber killed eight American civilians in an attack at a military base in southeastern Afghanistan on Wednesday, one of the highest foreign civilian death tolls in an insurgent strike in the eight-year war.

» More Top News
A security camera sits on a building in New York City March 6, 2008. REUTERS/Joshua Lott

Trial run in Times Square

Critics say the Sept. 11 trials will endanger America's most populated city. Will a $75-million New Year's Eve plan hold up as New York's security template?  Full Article 

U.S.
People walk past a branch of Bank of America in New York's financial district April 28, 2009. REUTERS/Brendan McDermid
Rolfe Winkler:

Move your money

Boycotting "too big to fail" banks is a great idea -- so long as investors remember that banks aren't the only ones responsible for the crisis.  Full Article 

    Commentary